Form 8-K - Current report:
SEC Accession No. 0001193125-24-237665
Filing Date
2024-10-15
Accepted
2024-10-15 17:15:29
Documents
13
Period of Report
2024-10-11
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d899308d8k.htm   iXBRL 8-K 25770
  Complete submission text file 0001193125-24-237665.txt   148157

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA wve-20241011.xsd EX-101.SCH 2876
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20241011_lab.xml EX-101.LAB 17928
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20241011_pre.xml EX-101.PRE 11256
15 EXTRACTED XBRL INSTANCE DOCUMENT d899308d8k_htm.xml XML 3612
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 241372672
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)